They finally indicated that the MCF-7 breast cancer cells transfected with a dominant-negative mutant of Spry2 proliferated faster and exhibited anchorage-independent growth in vitro and formed larger tumors in vivo. The gene discussed is SPRY2; the disease is breast carcinoma.